What is the standard intravenous N‑acetylcysteine dosing regimen for an adult with acute liver injury and abnormal liver function tests?

N-Acetylcysteine IV Dosing for Adults with Deranged LFTs

Direct Answer

For adults with acute liver failure and abnormal liver function tests, initiate IV N-acetylcysteine immediately using the standard 3-bag regimen: 150 mg/kg loading dose over 1 hour, followed by 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours (total 21-hour protocol), regardless of whether acetaminophen is the cause. 1, 2

Standard IV Dosing Protocol

The FDA-approved and guideline-recommended regimen consists of three sequential doses totaling 300 mg/kg over 21 hours 2:

• Loading dose: 150 mg/kg IV in 200 mL diluent over 1 hour (or 15 minutes per some protocols) 1, 2
• Second dose: 50 mg/kg IV in 500 mL diluent over 4 hours 1, 2
• Third dose: 100 mg/kg IV in 1000 mL diluent over 16 hours 1, 2

Critical preparation requirement: NAC must be diluted before administration as the concentrate is hyperosmolar (2600 mOsmol/L). Use sterile water, 0.45% sodium chloride, or 5% dextrose in water as diluent. 2

When to Initiate Treatment

Start NAC immediately in the following scenarios:

• Any suspected or confirmed acetaminophen overdose with rising aminotransferases, regardless of serum drug levels 1
• Acute liver failure of any etiology presenting with INR >1.5, any grade hepatic encephalopathy, or PT <50% 1, 3, 4
• Unknown etiology when circumstances of admission are inadequate or acetaminophen ingestion is possible 1
• Very high aminotransferases (>3500 IU/L), which are highly correlated with acetaminophen toxicity even without clear history 1

The AASLD strongly recommends beginning NAC promptly—do not wait for acetaminophen levels or other confirmatory tests if clinical suspicion exists. 1

Evidence for Non-Acetaminophen Liver Failure

NAC significantly improves outcomes even when acetaminophen is not the cause 1:

• Overall survival increases from 59% to 76% (OR 2.30,95% CI 1.54-3.45, p<0.0001) 1, 3, 4
• Transplant-free survival improves from 26% to 64% (OR 4.81,95% CI 3.22-7.18, p<0.0001) 1, 3, 4
• Post-transplant survival increases from 71.4% to 85.7% (OR 2.44,95% CI 1.11-5.37, p=0.03) 1

This represents a GRADE 2+ recommendation with strong agreement from the American Society of Anesthesiologists for NAC use in acute liver failure regardless of etiology. 1

Extended Duration Considerations

For massive overdose, co-ingestions, or pre-existing liver disease, consider extending treatment beyond 21 hours 2, 5:

• Check acetaminophen levels, ALT/AST, and INR after completing the standard 21-hour protocol 2
• Continue NAC at 100 mg/kg/day continuous infusion if acetaminophen remains detectable, transaminases are still rising, or INR remains elevated 3, 2
• Extended duration (beyond 72 hours) shows higher transplant-free survival (76.9% vs 41.4%, p=0.03) in non-acetaminophen acute liver failure 5
• Contact poison control (1-800-222-1222) or the acetaminophen overdose assistance line (1-800-525-6115) for guidance on extended dosing 2

Timing and Efficacy

Early administration is critical—benefits are greatest when NAC is started before progression to advanced encephalopathy 1, 3:

• Most effective when initiated within 8 hours of acetaminophen ingestion 6
• Still beneficial up to 24 hours post-ingestion 6
• May provide value even 48+ hours after ingestion in acetaminophen cases 1
• For non-acetaminophen liver failure, benefits are confined to patients with grades I-II encephalopathy rather than grades III-IV 1, 3, 7

Monitoring Requirements

Monitor the following parameters throughout NAC therapy 3, 2:

• Liver enzymes (AST/ALT) and INR: Every 12-24 hours 3, 7
• Hepatic encephalopathy grade: Continuous clinical assessment 3, 4
• Serum sodium: Maintain 140-145 mmol/L 3
• Glucose: Every 2 hours minimum 3
• Renal function and electrolytes: Throughout treatment 2

Safety Profile and Adverse Reactions

NAC is remarkably safe with minimal contraindications 1, 3, 4:

• Most common: Nausea and vomiting (manageable) 1, 3
• Skin reactions: Rash occurs in <5% of cases 1, 3
• Bronchospasm: Transient in 1-2% of patients 1, 3, 4
• Anaphylactoid reactions: Flushing and erythema typically occur 30-60 minutes after infusion starts and often resolve spontaneously 2

Management of hypersensitivity reactions 2:

• Temporarily interrupt infusion for mild reactions (flushing, erythema alone)
• Administer antihistamines for moderate reactions
• Immediately stop infusion for severe reactions (hypotension, wheezing, shortness of breath)
• Use extreme caution in patients with asthma—one fatal bronchospasm case reported 2

Critical Pitfalls to Avoid

• Do not delay NAC while awaiting acetaminophen levels if clinical presentation suggests acute liver failure 1
• Do not wait for fulminant hepatic failure to develop—early administration in grades I-II encephalopathy shows superior outcomes compared to later initiation 1, 3
• Do not assume the 21-hour protocol is always sufficient—massive overdoses and co-ingestions may require extended treatment 2, 5
• Do not use NAC from previously opened vials for IV administration 2
• Do not administer undiluted NAC—the hyperosmolar concentrate must be diluted to prevent complications 2
• Do not delay transplant evaluation in severe cases—NAC improves outcomes but does not eliminate the need for transplantation in refractory cases 3

Special Populations

In patients with pre-existing liver disease or chronic renal failure 1, 2:

• NAC is predominantly metabolized by the liver and can be given safely 1
• Monitor hepatic and renal function more frequently 2
• Consider extended duration beyond 21 hours as absorption and half-life of acetaminophen may be prolonged 2